Willingness to vaccinate against the coronavirus
How to cite
Thunstrom, Linda. 2020. "Willingness to vaccinate against the coronavirus." AEA RCT Registry. AEARCTR-0005576. https://doi.org/10.1257/rct.5576-1.0
Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.
* Primary investigator
Abstract
The purpose of this research is to examine how people would respond to a vaccine against the Coronavirus (COVID-19) and how that in turn would affect the length and severity of the Coronavirus outbreak in the U.S.
Specifically, subjects will get information about the estimated risks of the coronavirus, as well as an estimate of how effective a coronavirus vaccine might be, and thereafter state their willingness to vaccinate themselves, or any children in their household.
Given it is unclear at this point exactly what the risks are from the coronavirus in the U.S., we will vary information about the risks across subjects, such that they will be randomized into one of 8 information treatments. In other words, each subject will only face one of the treatments.
We foresee the project to deliver important information to policymakers on the willingness to vaccinate against the corona virus, once a vaccine has been developed. It is important to government agencies not only to ensure a vaccine is developed, but also to ensure the uptake of the vaccine is satisfactory. This project helps with the latter.
Intervention
Participants will be randomized into one of 8 treatments. In each treatment, they will receive different risk information about the corona virus, and thereafter asked about their willingness to vaccinate themselves and their family members.
The information will consist of the following (2x2) design for 4 treatments:
-High or low estimates of probability of catching the virus, based on most current information from the Centers for Disease Control and Prevention (CDC).
-High or low severity (risk of death) of the COVID-19, as determined by scientists.
Further, in an additional 4 treatments, the above information will be combined with:
Risk information that is lower, communicated by the White house.
Experimental design
Participants will be randomized into one of 8 treatments. In each treatment, they will receive different risk information about the corona virus, and thereafter asked about their willingness to vaccinate themselves and their family members.
The information will consist of the following (2x2) design for 4 treatments:
-High or low estimates of probability of catching the virus, based on most current information from the Centers for Disease Control and Prevention (CDC).
-High or low severity (risk of death) of the COVID-19, as determined by scientists.
Further, in an additional 4 treatments, the above information will be combined with:
Risk information that is lower, communicated by the White house.
Design details
Cited by
No citation data available for this registration yet.